Does ISOSORBIDE MONONITRATE Cause Metastatic neoplasm? 15 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Metastatic neoplasm have been filed in association with ISOSORBIDE MONONITRATE (Isosorbide Mononitrate). This represents 0.6% of all adverse event reports for ISOSORBIDE MONONITRATE.
15
Reports of Metastatic neoplasm with ISOSORBIDE MONONITRATE
0.6%
of all ISOSORBIDE MONONITRATE reports
0
Deaths
15
Hospitalizations
How Dangerous Is Metastatic neoplasm From ISOSORBIDE MONONITRATE?
Of the 15 reports, 15 (100.0%) required hospitalization.
Is Metastatic neoplasm Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ISOSORBIDE MONONITRATE. However, 15 reports have been filed with the FAERS database.
What Other Side Effects Does ISOSORBIDE MONONITRATE Cause?
Dizziness (554)
Headache (500)
Dyspnoea (462)
Chest pain (458)
Nausea (458)
Fatigue (446)
Diarrhoea (439)
Pruritus (416)
Myocardial infarction (409)
Malaise (405)
What Other Drugs Cause Metastatic neoplasm?
BEVACIZUMAB (133)
TRASTUZUMAB (120)
CAPECITABINE (102)
PACLITAXEL (102)
CARBOPLATIN (89)
LEUPROLIDE (84)
DOCETAXEL (72)
ADALIMUMAB (71)
RANITIDINE (71)
DENOSUMAB (68)
Which ISOSORBIDE MONONITRATE Alternatives Have Lower Metastatic neoplasm Risk?
ISOSORBIDE MONONITRATE vs ISOTRETINOIN
ISOSORBIDE MONONITRATE vs ISRADIPINE
ISOSORBIDE MONONITRATE vs ISTRADEFYLLINE
ISOSORBIDE MONONITRATE vs ITACITINIB
ISOSORBIDE MONONITRATE vs ITRACONAZOLE